COGT News and Press, Cogent Biosciences Inc Com From 11/02/21

Cogent Biosciences to Present Virtually at Jefferies London Healthcare Conference 2021 PR Newswire CAMBRIDGE, Mass. and BOULDER, Colo. , Nov. 2, 2021 /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on dev...

Cogent Biosciences Presents New Preclinical Data Demonstrating Bezuclastinib as a Differentiated KIT Inhibitor with Minimal Brain Penetration Currently enrolling APEX, a Phase 2 clinical study of bezuclastinib (CGT9486) for patients with Advanced Systemic Mastocytosis (AdvSM) ...

Cogent Biosciences to Present Preclinical Data on Bezuclastinib at AACR-NCI-EORTC Conference PR Newswire CAMBRIDGE, Mass. and BOULDER, Colo. , Oct. 1, 2021 /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused ...

Cogent Biosciences (NASDAQ:COGT): Q2 GAAP EPS of -$0.43 misses by $0.07.  As of June 30, 2021, company had cash and cash equivalents of $218.1M. Press Release For further details see: Cogent Biosciences EPS misses by $0.07

Cogent Biosciences Provides Corporate Updates and Reports Second Quarter 2021 Financial Results Initiated Phase 2 open-label clinical study (APEX) for bezuclastinib (CGT9486) in patients with Advanced Systemic Mastocytosis (AdvSM) SUMMIT study for patients with Non-Advanced ...

Cogent Biosciences to Present at Wedbush PacGrow Virtual Healthcare Conference 2021 PR Newswire CAMBRIDGE, Mass. and BOULDER, Colo. , July 27, 2021 /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on deve...

syahrir maulana/iStock via Getty Images Cogent Biosciences ([[COGT]] +0.5%) has received the FDA’s Orphan Drug Designation for a treatment targeted at gastrointestinal stromal tumors ((GIST)). GISTs making up less than 1% of all gastrointestinal tumors affect about ...

Cogent Biosciences to Present at Ladenburg Thalmann Virtual Healthcare Conference 2021 PR Newswire CAMBRIDGE, Mass. and BOULDER, Colo. , June 29, 2021 /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on develo...

Cogent Biosciences to Present at Jefferies Virtual Healthcare Conference 2021 PR Newswire CAMBRIDGE, Mass. and BOULDER, Colo. , May 26, 2021 /PRNewswire/ -- Cogent Biosciences, Inc. (Nasdaq: COGT), a biotechnology company focused on developing precision ...

Cogent Biosciences Provides Corporate Updates and Reports First Quarter 2021 Financial Results IND cleared for Phase 2 study of CGT9486, a selective mutant KIT inhibitor, in Advanced Systemic Mastocytosis patients John Robinson, PhD appointed as Chief Scientific Officer to l...